Uniphar hits its stride with strong maiden first half
Diversified healthcare company Uniphar (UPR:AIM) firmed 1% to €1.13 on well-received maiden interim results since listing in July 2019. These showed trading in-line with expectations, with revenues up 20% to €800.6m and profit before tax powering 175% higher to €13.8m.Chief executive officer Ger Rabbette said: 'The successful IPO of Uniphar in July provides a platform for a...
